Fredun Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹213.05 crore, reflecting a quarter-on-quarter *(QoQ) increase of 32.39 per cent from ₹160.93 crore. This corresponds to a year-on-year *(YoY) growth of 27.26 per cent.
Operating Profit
Operating Profit stands at ₹28.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.64 per cent from ₹26.34 crore. This corresponds to a year-on-year *(YoY) growth of 67.42 per cent.
PBDT
PBDT stands at ₹14.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.75 per cent from ₹15.78 crore. This corresponds to a year-on-year *(YoY) growth of 58.24 per cent.
Profit Before Tax
Profit Before Tax stands at ₹11.25 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.64 per cent from ₹14.00 crore. This corresponds to a year-on-year *(YoY) growth of 54.96 per cent.
Net Profit
Net Profit stands at ₹10.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.86 per cent from ₹10.48 crore. This represents a 79.67 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Fredun Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Fredun Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Fredun Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Fredun Pharmaceuticals Ltd Financial Reports
Fredun Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Fredun Pharma | -0.61% | 3.23% | 13.34% | 43.93% | 87.30% | 192.43% |
| Amrutanjan Healt | 0.92% | 1.64% | -3.18% | 2.82% | -11.53% | -24.78% |
| Jagsonpal Pharma | 1.98% | -0.99% | 11.27% | 20.31% | 31.03% | -7.46% |
| Shukra Pharma. | -0.03% | 4.24% | 14.95% | 6.20% | -26.10% | 66.02% |
| Syncom Formul. | 1.21% | 1.36% | -0.77% | 6.06% | 7.91% | -25.45% |
| Lincoln Pharma. | 0.94% | 0.21% | -3.13% | 6.73% | 27.24% | 12.30% |
| Fermenta Biotec. | 2.17% | 3.75% | 20.96% | 25.78% | 28.20% | 4.04% |
Company Info
Company Information
Chairman / Executive Director / Joint MD : Daulat N Medhora
Executive Director / Managing Director / CFO : Fredun N Medhora
Independent Non Exe. Director : Daisy Dsouza
Independent Non Exe. Director : Anshu Agarwal
Independent Non Exe. Director : Sonal Desai
Independent Non Exe. Director : Pooja Narendra Sanghavi
Company Sec. & Compli. Officer : Vaishnavi Rajkamal Sahu